(NYSE: BHC) Bausch Health Companies's forecast annual revenue growth rate of 1.85% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.64%.
Bausch Health Companies's revenue in 2025 is $9,858,000,000.On average, 3 Wall Street analysts forecast BHC's revenue for 2025 to be $3,734,536,837,742, with the lowest BHC revenue forecast at $3,727,560,373,584, and the highest BHC revenue forecast at $3,741,538,447,642. On average, 3 Wall Street analysts forecast BHC's revenue for 2026 to be $3,833,280,837,254, with the lowest BHC revenue forecast at $3,811,162,568,903, and the highest BHC revenue forecast at $3,865,048,414,188.
In 2027, BHC is forecast to generate $3,835,855,687,245 in revenue, with the lowest revenue forecast at $3,758,179,011,997 and the highest revenue forecast at $3,878,730,655,991.